Literature DB >> 8513587

A soluble form of the human transferrin receptor is released by activated lymphocytes in vitro.

W Woith1, I Nüsslein, C Antoni, D I Dejica, T H Winkler, M Herrmann, K Pirner, J R Kalden, B Manger.   

Abstract

Soluble transferrin receptors (sTfR) were detected in culture supernatants of activated human peripheral blood mononuclear cells (PBMC) using a sandwich ELISA technique with two non-cross-reacting TfR MoAbs. Mitogenic stimulation of lymphoid cells induced both up-regulation of TfR surface density and release of sTfR to the medium. Peak levels of sTfR in culture supernatants occurred at day 4 after activation, 1 day later than maximum expression of TfR in the plasma membrane. Production of sTfR was independent of proliferation, as demonstrated by measuring sTfR release by PBMC, which had been irradiated with a dose of 20 Gy before activation. In addition to these in vitro experiments, we tested the sera of 85 patients with systemic lupus erythematosus (SLE), an autoimmune disease accompanied by in vivo activation of lymphocytes, for their sTfR levels. No correlation of these data was detectable to serum concentrations of the soluble alpha-chain of the IL-2 receptor, an unequivocal marker of lymphocyte activation. However, they correlated negatively to the haemoglobin content of the patients' erythrocytes, indicating that erythroid progenitors are the predominant source of sTfR in SLE patients' sera.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8513587      PMCID: PMC1554787          DOI: 10.1111/j.1365-2249.1993.tb03434.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Release of soluble transferrin receptor from the surface of human leukemic HL60 cells.

Authors:  C R Chitambar; Z Zivkovic
Journal:  Blood       Date:  1989-08-01       Impact factor: 22.113

2.  Reticulocyte maturation and exosome release: transferrin receptor containing exosomes shows multiple plasma membrane functions.

Authors:  R M Johnstone; A Bianchini; K Teng
Journal:  Blood       Date:  1989-10       Impact factor: 22.113

3.  Serum transferrin receptor as a new index of erythropoiesis.

Authors:  Y Kohgo; Y Niitsu; H Kondo; J Kato; N Tsushima; K Sasaki; M Hirayama; T Numata; T Nishisato; I Urushizaki
Journal:  Blood       Date:  1987-12       Impact factor: 22.113

4.  A stem-loop in the 3' untranslated region mediates iron-dependent regulation of transferrin receptor mRNA stability in the cytoplasm.

Authors:  E W Müllner; L C Kühn
Journal:  Cell       Date:  1988-06-03       Impact factor: 41.582

5.  A transferrin receptor antibody represents one signal for the induction of IL 2 production by a human T cell line.

Authors:  B Manger; A Weiss; K J Hardy; J D Stobo
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

6.  A high yield purification of the human transferrin receptor and properties of its major extracellular fragment.

Authors:  A P Turkewitz; J F Amatruda; D Borhani; S C Harrison; A L Schwartz
Journal:  J Biol Chem       Date:  1988-06-15       Impact factor: 5.157

7.  Transferrin receptors in rat plasma.

Authors:  Y Beguin; H A Huebers; B Josephson; C A Finch
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

8.  Circulating transferrin receptor in human serum.

Authors:  Y Kohgo; T Nishisato; H Kondo; N Tsushima; Y Niitsu; I Urushizaki
Journal:  Br J Haematol       Date:  1986-10       Impact factor: 6.998

9.  The value of complement and immune complex determinations in monitoring disease activity in patients with systemic lupus erythematosus.

Authors:  R M Valentijn; H van Overhagen; H M Hazevoet; J Hermans; A Cats; M R Daha; L A van ES
Journal:  Arthritis Rheum       Date:  1985-08

10.  Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.

Authors:  L A Rubin; C C Kurman; M E Fritz; W E Biddison; B Boutin; R Yarchoan; D L Nelson
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

View more
  1 in total

Review 1.  Transferrin receptor-mediated endocytosis: a useful target for cancer therapy.

Authors:  Stephanie Tortorella; Tom C Karagiannis
Journal:  J Membr Biol       Date:  2014-02-27       Impact factor: 1.843

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.